D. Kyle Hogarth

4.6k total citations
94 papers, 2.5k citations indexed

About

D. Kyle Hogarth is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cancer Research. According to data from OpenAlex, D. Kyle Hogarth has authored 94 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 32 papers in Physiology and 11 papers in Cancer Research. Recurrent topics in D. Kyle Hogarth's work include Lung Cancer Diagnosis and Treatment (24 papers), Asthma and respiratory diseases (22 papers) and Tracheal and airway disorders (18 papers). D. Kyle Hogarth is often cited by papers focused on Lung Cancer Diagnosis and Treatment (24 papers), Asthma and respiratory diseases (22 papers) and Tracheal and airway disorders (18 papers). D. Kyle Hogarth collaborates with scholars based in United States, China and Denmark. D. Kyle Hogarth's co-authors include Septimiu Murgu, Balaji Laxmanan, Edward T. Naureckas, Steven R. White, Amit Mahajan, Karen Dugan, Diana Doeing, Anne I. Sperling, Julian Solway and Abhinav Agrawal and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

D. Kyle Hogarth

90 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Kyle Hogarth United States 30 1.6k 852 414 348 232 94 2.5k
Kosmas Tsakiridis Greece 32 1.7k 1.1× 236 0.3× 297 0.7× 955 2.7× 385 1.7× 122 2.8k
Μarios E. Froudarakis Greece 35 2.4k 1.5× 691 0.8× 435 1.1× 667 1.9× 681 2.9× 151 3.8k
George A. Eapen United States 32 2.3k 1.5× 263 0.3× 368 0.9× 618 1.8× 422 1.8× 100 3.3k
Rodolfo C. Morice United States 35 2.4k 1.5× 256 0.3× 508 1.2× 777 2.2× 500 2.2× 109 3.6k
Nikolaos Katsikogiannis Greece 33 1.7k 1.1× 232 0.3× 236 0.6× 1.1k 3.1× 300 1.3× 84 2.9k
Nikolaos Machairiotis Greece 31 1.4k 0.9× 200 0.2× 220 0.5× 921 2.6× 248 1.1× 109 2.7k
Ralph J. Panos United States 29 1.7k 1.1× 358 0.4× 635 1.5× 336 1.0× 133 0.6× 90 2.7k
Jouke T. Annema Netherlands 36 3.9k 2.5× 660 0.8× 153 0.4× 1.0k 3.0× 448 1.9× 171 4.8k
Erich Stoelben Germany 26 1.6k 1.0× 142 0.2× 249 0.6× 548 1.6× 602 2.6× 147 2.6k
Sow-Hsong Kuo Taiwan 25 1.2k 0.7× 323 0.4× 423 1.0× 346 1.0× 434 1.9× 70 2.1k

Countries citing papers authored by D. Kyle Hogarth

Since Specialization
Citations

This map shows the geographic impact of D. Kyle Hogarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Kyle Hogarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Kyle Hogarth more than expected).

Fields of papers citing papers by D. Kyle Hogarth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Kyle Hogarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Kyle Hogarth. The network helps show where D. Kyle Hogarth may publish in the future.

Co-authorship network of co-authors of D. Kyle Hogarth

This figure shows the co-authorship network connecting the top 25 collaborators of D. Kyle Hogarth. A scholar is included among the top collaborators of D. Kyle Hogarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Kyle Hogarth. D. Kyle Hogarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sue, Richard, et al.. (2024). TARGETED LUNG DENERVATION IN COPD: OUTCOMES FROM THE AIRFLOW-3 OPEN LABEL COHORT. CHEST Journal. 166(4). A6465–A6467. 2 indexed citations
2.
Koster, T. David, Pallav L. Shah, Arschang Valipour, et al.. (2024). Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves. Respiratory Medicine. 227. 107639–107639. 2 indexed citations
3.
Hogarth, D. Kyle, et al.. (2024). Efficacy and safety of the Spiration Valve System™ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE). Respiratory Medicine. 224. 107565–107565. 1 indexed citations
4.
Sciurba, Frank C., Mark T. Dransfield, Victor Kim, et al.. (2023). Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx. BMJ Open Respiratory Research. 10(1). e001710–e001710. 5 indexed citations
6.
Murgu, Septimiu, et al.. (2020). Improving diagnostic yield of navigational bronchoscopy for peripheral pulmonary lesions: a review of advancing technology. Journal of Thoracic Disease. 12(12). 7683–7690. 13 indexed citations
7.
Abu‐Hijleh, Muhanned, Vikram Anand, Lonny Yarmus, et al.. (2019). Intrabronchial Valves for Air Leaks After Lobectomy, Segmentectomy, and Lung Volume Reduction Surgery. Lung. 197(5). 627–633. 9 indexed citations
8.
Chaddha, Udit, D. Kyle Hogarth, & Septimiu Murgu. (2019). Bronchoscopic Ablative Therapies for Malignant Central Airway Obstruction and Peripheral Lung Tumors. Annals of the American Thoracic Society. 16(10). 1220–1229. 32 indexed citations
9.
Chaddha, Udit, D. Kyle Hogarth, & Septimiu Murgu. (2019). The role of endobronchial ultrasound transbronchial needle aspiration for programmed death ligand 1 testing and next generation sequencing in advanced non-small cell lung cancer. Annals of Translational Medicine. 7(15). 351–351. 15 indexed citations
10.
Hogarth, D. Kyle, et al.. (2019). An NP's guide to diagnosing and treating alpha-1 antitrypsin deficiency. The Nurse Practitioner. 44(4). 13–21. 1 indexed citations
11.
Morris, Scott, Anil Vachani, Harvey I. Pass, et al.. (2018). Whole blood FPR1 mRNA expression predicts both non‐small cell and small cell lung cancer. International Journal of Cancer. 142(11). 2355–2362. 14 indexed citations
12.
Murtagh, Gillian, Luke J. Laffin, John F. Beshai, et al.. (2016). Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction. Circulation Cardiovascular Imaging. 9(1). e003738–e003738. 148 indexed citations
13.
Sandhaus, Robert A., Gerard Turino, Mark Brantly, et al.. (2016). The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 3(3). 668–682. 140 indexed citations
14.
Denner, Darcy, Diana Doeing, D. Kyle Hogarth, et al.. (2015). Airway Inflammation after Bronchial Thermoplasty for Severe Asthma. Annals of the American Thoracic Society. 12(9). 1302–1309. 63 indexed citations
15.
Denner, Darcy, Naseer Sangwan, D. Kyle Hogarth, et al.. (2015). Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. Journal of Allergy and Clinical Immunology. 137(5). 1398–1405.e3. 118 indexed citations
16.
Murtagh, Gillian, John F. Beshai, Catherine A. Bonham, et al.. (2014). Abstract 16689: Can Cardiovascular Magnetic Resonance Identify Patients With Cardiac Sarcoidosis and Preserved Left Ventricular Ejection Fraction at Risk for Death and Sustained Ventricular Tachycardia?. Circulation. 1 indexed citations
17.
Doeing, Diana, Aliya N. Husain, Edward T. Naureckas, Steven R. White, & D. Kyle Hogarth. (2013). Bronchial thermoplasty failure in severe persistent asthma: a case report. Journal of Asthma. 50(7). 799–801. 18 indexed citations
18.
Patel, Amit R., Sonal Chandra, Kirk T. Spencer, et al.. (2011). Myocardial Damage in Patients with Sarcoidosis and Preserved Left Ventricular Systolic Function: An Observational Study. European Journal of Heart Failure. 13(11). 1231–1237. 79 indexed citations
19.
Frank, Karen M., D. Kyle Hogarth, Jonathan Miller, et al.. (2009). Investigation of the Cause of Death in a Gene-Therapy Trial. New England Journal of Medicine. 361(2). 161–169. 57 indexed citations
20.
Rachelefsky, Gary S. & D. Kyle Hogarth. (2008). Issues in the diagnosis of α1-antitrypsin deficiency. Journal of Allergy and Clinical Immunology. 121(4). 833–838. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026